Vicarious Surgical (RBOT) Income from Continuing Operations (2020 - 2025)
Vicarious Surgical (RBOT) reported Income from Continuing Operations of 11058000.0 for Q3 2025, up 35.3% year-over-year from 8172992.48 in Q3 2024, and up 16.32% on a QoQ basis from 13215000.0 in Q2 2025.
Vicarious Surgical (RBOT) has 6 years of Income from Continuing Operations data on file, last reported at 11058000.0 in Q3 2025.
- Quarterly Income from Continuing Operations rose 35.3% year-over-year to 11058000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was 53593000.0 (up 14.12% YoY) and the FY2024 annual result came in at 63223000.0, up 11.04% from the prior year.
- Income from Continuing Operations climbed to 11058000.0 in Q3 2025 per RBOT's latest filing, from 13215000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 42527000.0 in Q1 2022 and bottomed at 45124000.0 in Q3 2021.
- The 5-year median for Income from Continuing Operations is 13926000.0 (2024), against an average of 10737421.05.
- The widest annual swing landed in 2021, when Income from Continuing Operations slumped 24757.7%; it then surged 912.98% in 2022.
- Tracing RBOT's Income from Continuing Operations over 5 years: stood at 21786000.0 in 2021, then tumbled by 151.32% to 11180000.0 in 2022, then fell by 17.27% to 13111000.0 in 2023, then retreated by 6.22% to 13926000.0 in 2024, then climbed by 20.59% to 11058000.0 in 2025.
- Per Business Quant, the three latest RBOT Income from Continuing Operations figures stand at 11058000.0 (Q3 2025), 13215000.0 (Q2 2025), and 15394000.0 (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 220.30 Mn |
| 10 | Vicarious Surgical | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -11.06 Mn |
| Jun 30, 2025 | -13.22 Mn |
| Mar 31, 2025 | -15.39 Mn |
| Dec 31, 2024 | -13.93 Mn |
| Sep 30, 2024 | -17.09 Mn |
| Jun 30, 2024 | -15.21 Mn |
| Mar 31, 2024 | -17.00 Mn |
| Dec 31, 2023 | -13.11 Mn |
| Sep 30, 2023 | -15.70 Mn |
| Jun 30, 2023 | -15.33 Mn |
| Mar 31, 2023 | -26.92 Mn |
| Dec 31, 2022 | -11.18 Mn |
| Sep 30, 2022 | -24.74 Mn |
| Jun 30, 2022 | -1.45 Mn |
| Mar 31, 2022 | 42.53 Mn |
| Dec 31, 2021 | 21.79 Mn |
| Sep 30, 2021 | -45.12 Mn |
| Jun 30, 2021 | -6.64 Mn |
| Mar 31, 2021 | -5.23 Mn |
| Dec 31, 2020 | -3.78 Mn |
| Sep 30, 2020 | -3.34 Mn |
| Jun 30, 2020 | -26,704.00 |